← Leaderboards
Frederick Gerard Moeller
Virginia Commonwealth University
$65,095,599
Attributed
$70,219,248
Total exposure
30
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$89,432,228 · 32
By mechanism
UL1$24,834,068 · 2
P50$24,365,429 · 7
U54$13,033,092 · 6
UM1$12,325,812 · 1
UG3$5,562,421 · 3
UG1$3,080,593 · 1
Top collaborators
- Albert Arias6 shared
- Arun J Sanyal2 shared
- Juan Pablo Arab1 shared
- Kathryn A. Cunningham1 shared
- Matthew Sean Halquist1 shared
- Caitlin Eileen Martin1 shared
- Charles O'Keeffe1 shared
- Qingguo Xu1 shared
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Albert Arias$6,848,452
- Qingguo Xu$4,396,626
- Matthew Sean Halquist$1,629,321
- Charles O'Keeffe$403,667
- Caitlin Eileen Martin$3,787,017
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsCocaineClinical ResearchSerotoninTranslational ResearchBaseResponseFundingBrainBehavioralPre-ClinicalResourcesCocaine UseImpulsivityCuesCue ReactivitySelf AdministrationProgramsNational Institute Of Drug AbuseCollaborationsUniversitiesResearch PersonnelTrainingInstitution
Grant awards (126)
Wright Regional Center for Clinical and Translational Science$3,954,814
UM1 · FY2025 · TR · contact PI
Novel 5-HT2A/mGluR5 Antagonist for Opioid Use Disorder$1,153,945
UG3 · FY2025 · DA · contact PI
Integrated Therapies for Alcohol use in Alcohol-associated Liver Disease (ITAALD) - Virginia Commonwealth University$341,550
U01 · FY2025 · AA
Wright Regional Center for Clinical and Translational Science$3,973,592
UM1 · FY2024 · TR · contact PI
Laboratories for Early Clinical Evaluation of Pharmacotherapies for Substance Use Disorders$504,103
UG1 · FY2024 · DA · contact PI
Integrated Therapies for Alcohol use in Alcohol-associated Liver Disease (ITAALD) - Virginia Commonwealth University$341,550
U01 · FY2024 · AA
Wright Regional Center for Clinical and Translational Science$215,488
UM1 · FY2024 · TR · contact PI
Wright Regional Center for Clinical and Translational Science$158,510
UM1 · FY2024 · TR · contact PI
Wright Regional Center for Clinical and Translational Science$4,023,408
UM1 · FY2023 · TR · contact PI
Laboratories for Early Clinical Evaluation of Pharmacotherapies for Substance Use Disorders$647,076
UG1 · FY2023 · DA · contact PI
Center for Clinical and Translational Research$3,703,862
UL1 · FY2022 · TR · contact PI
Laboratories for Early Clinical Evaluation of Pharmacotherapies for Substance Use Disorders$757,571
UG1 · FY2022 · DA · contact PI
Center for Clinical and Translational Research$3,703,862
UL1 · FY2021 · TR · contact PI
Laboratories for Early Clinical Evaluation of Pharmacotherapies for Substance Use Disorders$511,982
UG1 · FY2021 · DA · contact PI
Olanzapine Augmentation in OUD Patients on Buprenorphine-Naloxone with Comorbid Symptoms of Serious Mental Illness (SMI): A Prospective Observational 8-week Pilot Study$147,343
UG1 · FY2021 · DA · contact PI
Center for Clinical and Translational Research$3,843,774
UL1 · FY2020 · TR · contact PI
NOP Receptor Antagonist for OUD Pharmacotherapy$2,793,808
UG3 · FY2020 · DA
Laboratories for Early Clinical Evaluation of Pharmacotherapies for Substance Use Disorders$512,518
UG1 · FY2020 · DA · contact PI
N3C & All of Us Research Program Collaborative Project$346,608
UL1 · FY2020 · TR · contact PI
Quality Assurance and Reporting$117,816
UL1 · FY2020 · TR · contact PI
Center for Clinical and Translational Research$3,561,541
UL1 · FY2019 · TR · contact PI
Novel LAAM formulations to treat Opioid Use Disorder (UG3 DA048768-01A1)$1,614,668
UG3 · FY2019 · DA
Research Supplement to Promote Diversity in Health Related Research$295,053
UL1 · FY2019 · TR · contact PI
Center for Clinical and Translational Research$3,570,579
UL1 · FY2018 · TR · contact PI
Medication Development Center for cocaine Use Disorder$1,238,097
U54 · FY2018 · DA · contact PI
Medication Development Center for cocaine Use Disorder$499,661
U54 · FY2018 · DA · contact PI
Preclinical Assessment of Compounds for Cocaine Use Disorder (CocUD)$291,156
U54 · FY2018 · DA · contact PI
Medication Development Center for Cocaine Use Disorder$277,273
U54 · FY2018 · DA · contact PI
Medication Development Center for Cocaine Use Disorder$253,833
U54 · FY2018 · DA · contact PI
Medication Development Center for Cocaine Use Disorder$244,495
U54 · FY2018 · DA · contact PI
Medication Development Center for Cocaine Use Disorder$171,340
U54 · FY2018 · DA · contact PI
Medication Development Center for cocaine Use Disorder$1,314,565
U54 · FY2017 · DA · contact PI
Preclinical Assessment of Compounds for Cocaine Use Disorder (CocUD)$308,671
U54 · FY2017 · DA · contact PI
Medication Development Center for Cocaine Use Disorder$292,034
U54 · FY2017 · DA · contact PI
Serotonergic Regulation of Corticostriatal Connectivity in Cocaine Dependence$273,287
P50 · FY2017 · DA · contact PI
Medication Development Center for Cocaine Use Disorder$268,583
U54 · FY2017 · DA · contact PI
Medication Development Center for Cocaine Use Disorder$259,224
U54 · FY2017 · DA · contact PI
Medication Development Center for Cocaine Use Disorder$186,053
U54 · FY2017 · DA · contact PI
Medication Development Center for cocaine Use Disorder$1,233,588
U54 · FY2016 · DA · contact PI
Medication Development Center for Cocaine Use Disorder$303,548
U54 · FY2016 · DA · contact PI
Preclinical Assessment of Compounds for Cocaine Use Disorder (CocUD)$285,855
U54 · FY2016 · DA · contact PI
Serotonergic Regulation of Corticostriatal Connectivity in Cocaine Dependence$270,555
P50 · FY2016 · DA · contact PI
Medication Development Center for Cocaine Use Disorder$268,246
U54 · FY2016 · DA · contact PI
Medication Development Center for Cocaine Use Disorder$239,157
U54 · FY2016 · DA · contact PI
Medication Development Center for Cocaine Use Disorder$136,781
U54 · FY2016 · DA · contact PI
Medication Development Center for cocaine Use Disorder$73,200
U54 · FY2016 · DA · contact PI
Center for Clinical and Translational Research$2,158,928
UL1 · FY2015 · TR · contact PI
Medication Development Center for cocaine Use Disorder$1,224,173
U54 · FY2015 · DA · contact PI
Serotonergic Regulation of Corticostriatal Connectivity in Cocaine Dependence$326,109
P50 · FY2015 · DA · contact PI
Preclinical Assessment of Compounds for Cocaine Use Disorder (CocUD)$289,907
U54 · FY2015 · DA · contact PI
Medication Development Center for Cocaine Use Disorder$275,934
U54 · FY2015 · DA · contact PI
Medication Development Center for Cocaine Use Disorder$268,640
U54 · FY2015 · DA · contact PI
Medication Development Center for Cocaine Use Disorder$246,552
U54 · FY2015 · DA · contact PI
Medication Development Center for Cocaine Use Disorder$143,140
U54 · FY2015 · DA · contact PI
Center for Clinical and Translational Research$3,417,821
UL1 · FY2014 · TR · contact PI
Medication Development Center for cocaine Use Disorder$1,219,693
U54 · FY2014 · DA · contact PI
Administrative Core$772,183
P50 · FY2014 · DA · contact PI
Center for Clinical and Translational Research$427,924
KL2 · FY2014 · TR · contact PI
Brain Function and Structure in Cocaine Dependence Treatment$333,534
P50 · FY2014 · DA · contact PI
Medication Development Center for Cocaine Use Disorder$306,554
U54 · FY2014 · DA · contact PI
Serotonergic Regulation of Corticostriatal Connectivity in Cocaine Dependence$273,288
P50 · FY2014 · DA · contact PI
Medication Development Center for Cocaine Use Disorder$270,956
U54 · FY2014 · DA · contact PI
Preclinical Assessment of Compounds for Cocaine Use Disorder (CocUD)$262,447
U54 · FY2014 · DA · contact PI
Medication Development Center for Cocaine Use Disorder$241,574
U54 · FY2014 · DA · contact PI
Medication Development Center for Cocaine Use Disorder$138,162
U54 · FY2014 · DA · contact PI
Center for Clinical and Translational Research$114,224
UL1 · FY2014 · TR · contact PI
Administrative Core$869,520
P50 · FY2013 · DA · contact PI
Brain Function and Structure in Cocaine Dependence Treatment$364,462
P50 · FY2013 · DA · contact PI
Serotonergic Regulation of Corticostriatal Connectivity in Cocaine Dependence$290,679
P50 · FY2013 · DA · contact PI
Administrative Core$1,000,548
P50 · FY2012 · DA · contact PI
Brain Function and Structure in Cocaine Dependence Treatment$407,840
P50 · FY2012 · DA · contact PI
CLINICAL NEUROBIOLOGY OF SEROTONIN AND ADDICTION$229,529
P20 · FY2012 · DA · contact PI
Substance Abuse Research - Medications Development Center$2,043,336
P50 · FY2011 · DA · contact PI
Administrative Core$862,701
P50 · FY2011 · DA · contact PI
Brain Function and Structure in Cocaine Dependence Treatment$307,727
P50 · FY2011 · DA · contact PI
Serotonin, Impulsivity, and Substance Abuse$117,612
K02 · FY2011 · DA · contact PI
Substance Abuse Research - Medications Development Center$2,079,960
P50 · FY2010 · DA · contact PI
Administrative Core$873,007
P50 · FY2010 · DA · contact PI
CLINICAL NEUROBIOLOGY OF SEROTONIN AND ADDICTION$308,465
P20 · FY2010 · DA · contact PI
Brain Function and Structure in Cocaine Dependence Treatment$305,286
P50 · FY2010 · DA · contact PI
Serotonin, Impulsivity, and Substance Abuse$117,612
K02 · FY2010 · DA · contact PI
Substance Abuse Medications Development Research Center$2,766,981
P50 · FY2009 · DA · contact PI
IMPULSIVITY, BRAIN FUNCTION & SUBSTANCE ABUSE TREATMENT$1,018,168
P50 · FY2009 · DA · contact PI
ADMINISTRATIVE AND SCIENTIFIC CORE$334,089
P50 · FY2009 · DA · contact PI
CLINICAL NEUROBIOLOGY OF SEROTONIN AND ADDICTION$311,451
P20 · FY2009 · DA · contact PI
Serotonin, Impulsivity, and Substance Abuse$117,612
K02 · FY2009 · DA · contact PI
Substance Abuse Research--Medications Development Center$2,762,622
P50 · FY2008 · DA · contact PI
IMPULSIVITY, BRAIN FUNCTION & SUBSTANCE ABUSE TREATMENT$960,515
P50 · FY2008 · DA · contact PI
ADMINISTRATIVE AND SCIENTIFIC CORE$528,872
P50 · FY2008 · DA · contact PI
CLINICAL NEUROBIOLOGY OF SEROTONIN AND ADDICTION$311,832
P20 · FY2008 · DA · contact PI
Tiagabine and Disulfiram for Cocaine Dependence$125,790
P50 · FY2008 · DA · contact PI
Serotonin, Impulsivity, and Substance Abuse$117,612
K02 · FY2008 · DA · contact PI
Substance Abuse Research--Medications Development Center$2,757,104
P50 · FY2007 · DA · contact PI
IMPULSIVITY, BRAIN FUNCTION & SUBSTANCE ABUSE TREATMENT$613,300
P50 · FY2007 · DA · contact PI
CLINICAL NEUROBIOLOGY OF SEROTONIN AND ADDICTION$228,558
P20 · FY2007 · DA · contact PI
Tiagabine and Disulfiram for Cocaine Dependence$139,821
P50 · FY2007 · DA · contact PI
Serotonin, Impulsivity, and Substance Abuse$117,612
K02 · FY2007 · DA · contact PI
IMPULSIVITY, BRAIN FUNCTION & SUBSTANCE ABUSE TREATMENT$363,164
P50 · FY2006 · DA · contact PI
Serotonin, Drug Use and MDMA Induced Deficits$371,250
R01 · FY2005 · DA
IMPULSIVITY, BRAIN FUNCTION &SUBSTANCE ABUSE TREATMENT$340,981
P50 · FY2005 · DA
SEROTONIN, DRUG USE, AND MDMA INDUCED DEFICITS$40,538
M01 · FY2005 · RR
Scientific Meeting of ISRI$25,000
R13 · FY2005 · DA
LABORATORY STUDIES OF L-DOPA AND PSYCHOMOTOR STIMULANTS$16,215
M01 · FY2005 · RR
SEROTONIN AND AGGRESSION IN COCAINE DEPENDENCE$4,865
M01 · FY2005 · RR
Serotonin, Drug Use and MDMA Induced Deficits$297,000
R01 · FY2004 · DA
SEROTONIN, IMPULSIVITY AND COCAINE DEPENDENCE TREATMENT$249,430
R01 · FY2004 · DA
SEROTONIN, IMPULSE CONTROL, AND SUBSTANCE ABUSE$119,923
K02 · FY2004 · DA
Serotonin, Drug Use and MDMA Induced Deficits$74,250
R01 · FY2004 · DA
Laboratory studies of L-dopa and psychomotor stimulants$13,902
M01 · FY2004 · RR
Serotonin and aggression in cocaine dependence$5,296
M01 · FY2004 · RR
Serotonin, Drug Use and MDMA Induced Deficits$295,945
R01 · FY2003 · DA
SEROTONIN, IMPULSIVITY AND COCAINE DEPENDENCE TREATMENT$252,514
R01 · FY2003 · DA
SEROTONIN, IMPULSE CONTROL, AND SUBSTANCE ABUSE$119,923
K02 · FY2003 · DA
SEROTONIN, IMPULSIVITY AND COCAINE DEPENDENCE TREATMENT$296,126
R01 · FY2002 · DA
SEROTONIN, IMPULSE CONTROL, AND SUBSTANCE ABUSE$119,923
K02 · FY2002 · DA
ANTISOCIAL PERSONALITY AND ALCOHOL INDUCED AGGRESSION$0
M01 · FY2002 · RR
SEROTONIN AND AGGRESSION IN COCAINE DEPENDENCE$0
M01 · FY2002 · RR
SEROTONIN, IMPULSIVITY AND COCAINE DEPENDENCE TREATMENT$255,174
R01 · FY2001 · DA
SEROTONIN, IMPULSE CONTROL, AND SUBSTANCE ABUSE$119,923
K02 · FY2001 · DA
SEROTONIN, IMPULSIVITY AND COCAINE DEPENDENCE TREATMENT$41,814
R01 · FY2001 · DA
ANTISOCIAL PERSONALITY AND ALCOHOL INDUCED AGGRESSION$0
M01 · FY2001 · RR
SEROTONIN AND AGGRESSION IN COCAINE DEPENDENCE$0
M01 · FY2001 · RR
SEROTONIN, IMPULSIVITY AND COCAINE DEPENDENCE TREATMENT$272,732
R01 · FY2000 · DA
SEROTONIN, IMPULSE CONTROL, AND SUBSTANCE ABUSE$119,923
K02 · FY2000 · DA
ANTISOCIAL PERSONALITY AND ALCOHOL INDUCED AGGRESSION$15,114
M01 · FY2000 · RR
SEROTONIN AND AGGRESSION IN COCAINE DEPENDENCE$15,114
M01 · FY2000 · RR